AwardTape · Defense awards · Medical · Drugs and biologicals · N6809522P0012
N6809522P0012: -$26K purchase order to RLS (usa) Inc
RLS (usa) Inc holds a purchase order from Defense Health Agency with -$26K obligated since Oct 2023 and $34K obligated over its life, against a ceiling of $51K. Latest action Aug 13, 2024.
Radiopharmaceutical supplies
| PIID | N6809522P0012 |
|---|---|
| Type | purchase order |
| Company | RLS (usa) Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY HCD WEST |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325412 PHARMACEUTICAL PREPARATION MANUFACTURING |
| Obligated since Oct 2023 | -$26K |
| Total obligated (lifetime) | $34K |
| Ceiling (base and all options) | $51K |
| Base date | May 11, 2022 |
| Latest action | Aug 13, 2024 |
| End date | Dec 31, 2024 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed |
| Place of performance | FL |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial